Non-small Cell Lung Cancers: Clinical Trials

5 trials for Non-small Cell Lung Cancers, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 unknown. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Phase 22Terminated 1, Unknown 1

Follow Non-small Cell Lung Cancers: new trials by email Literature Review of Non-small Cell Lung Cancers trials Research Report on Non-small Cell Lung Cancers

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
PRT3789, pembrolizumab - Advanced Solid Tumor, Esophageal Cancer
Phase 2TerminatedPrelude Therapeutics Incorporated62025-06-032026-02-02
Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers
Adagrasib, Olaparib - Advanced Solid Tumor, Non-small Cell Lung Cancers
Phase 1TerminatedM.D. Anderson Cancer Center12024-01-302026-04-09
PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation
PRT3789, Docetaxel - Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1CompletedPrelude Therapeutics Incorporated1352023-05-022025-10-16
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
PRT3645 - Breast Cancer, Glioblastoma
Phase 1CompletedPrelude Therapeutics Incorporated222022-12-272024-07-01
Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers
stereotactic ablative radiotherapy (SABR), Pentoxifylline - Non-small Cell Lung Cancers
Phase 2UnknownUniversity of Louisville592013-10-012024-02-07

Narrower conditions

Neoplasm Metastasis (2)  ·  Breast Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Glioblastoma (1)  ·  Mesothelioma, Malignant (1)  ·  Sarcoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Neoplasms (3)  ·  Head and Neck Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Neoplastic Processes (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Adenoma (1)  ·  Astrocytoma (1)  ·  Breast Diseases (1)  ·  Carcinoma (1)  ·  Carcinoma, Squamous Cell (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Esophageal Diseases (1)  ·  Female Urogenital Diseases (1)

Interventions

Docetaxel (1)  ·  Pentoxifylline (1)  ·  adagrasib (1)  ·  olaparib (1)  ·  pembrolizumab (1)

Sponsors

Prelude Therapeutics Incorporated (3)  ·  M.D. Anderson Cancer Center (1)  ·  University of Louisville (1)

Countries

United States (5)  ·  Singapore (2)  ·  Spain (2)  ·  France (1)  ·  Netherlands (1)

Top investigators

Neal E Dunlap, MD (1)  ·  Timothy Yap, MD (1)